Trial Profile
Collection of Patients' Background Information Relenza Sentinel Site Monitoring Program in Japan
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Sep 2023
Price :
$35
*
At a glance
- Drugs Zanamivir (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions
- Acronyms SSMP
- Sponsors GSK
- 23 Sep 2010 New trial record